Anti-CHAD/ SLRR4A functional antibody

Anti-CHAD/ SLRR4A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CHAD/CHAD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0773-Ab-1/ GM-Tg-hg-SE0773-Ab-2Anti-Human CHAD monoclonal antibodyHuman
GM-Tg-rg-SE0773-Ab-1/ GM-Tg-rg-SE0773-Ab-2Anti-Rat CHAD monoclonal antibodyRat
GM-Tg-mg-SE0773-Ab-1/ GM-Tg-mg-SE0773-Ab-2Anti-Mouse CHAD monoclonal antibodyMouse
GM-Tg-cynog-SE0773-Ab-1/ GM-Tg-cynog-SE0773-Ab-2Anti-Cynomolgus/ Rhesus macaque CHAD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0773-Ab-1/ GM-Tg-felg-SE0773-Ab-2Anti-Feline CHAD monoclonal antibodyFeline
GM-Tg-cang-SE0773-Ab-1/ GM-Tg-cang-SE0773-Ab-2Anti-Canine CHAD monoclonal antibodyCanine
GM-Tg-bovg-SE0773-Ab-1/ GM-Tg-bovg-SE0773-Ab-2Anti-Bovine CHAD monoclonal antibodyBovine
GM-Tg-equg-SE0773-Ab-1/ GM-Tg-equg-SE0773-Ab-2Anti-Equine CHAD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0773-Ab-1/ GM-Tg-hg-SE0773-Ab-2; GM-Tg-rg-SE0773-Ab-1/ GM-Tg-rg-SE0773-Ab-2;
GM-Tg-mg-SE0773-Ab-1/ GM-Tg-mg-SE0773-Ab-2; GM-Tg-cynog-SE0773-Ab-1/ GM-Tg-cynog-SE0773-Ab-2;
GM-Tg-felg-SE0773-Ab-1/ GM-Tg-felg-SE0773-Ab-2; GM-Tg-cang-SE0773-Ab-1/ GM-Tg-cang-SE0773-Ab-2;
GM-Tg-bovg-SE0773-Ab-1/ GM-Tg-bovg-SE0773-Ab-2; GM-Tg-equg-SE0773-Ab-1/ GM-Tg-equg-SE0773-Ab-2
Products NameAnti-CHAD monoclonal antibody
Formatmab
Target NameCHAD
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHAD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0773-Ag-1Recombinant multi-species CHAD/ SLRR4A protein


    Target information

    Target IDGM-SE0773
    Target NameCHAD
    Gene ID1101,12643,29195,702601,609296,111557728,281069,100147607
    Gene Symbol and SynonymsCHAD,SLRR4A
    Uniprot AccessionO15335,O70210,Q27972
    Uniprot Entry NameCHAD_HUMAN,CHAD_RAT,CHAD_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136457
    Target ClassificationN/A

    The target: CHAD, gene name: CHAD, also named as SLRR4A. Chondroadherin is a cartilage matrix protein thought to mediate adhesion of isolated chondrocytes.  The protein contains 11 leucine-rich repeats flanked by cysteine-rich regions. The chondroadherin messenger RNA is present in chondrocytes at all ages. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.